Skip to main content

ARROWHEAD PHARMACEUTICALS, INC.

corporate_fare Company Profile

ARROWHEAD PHARMACEUTICALS, INC.

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Exchange: NASDAQSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed ARWR - Latest Insights

ARWR
Apr 23, 2026, 4:44 PM EDT
Filing Type: 144
Importance Score:
7
ARWR
Mar 20, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
ARWR
Feb 05, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
9
ARWR
Feb 05, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
9
ARWR
Jan 26, 2026, 5:32 PM EST
Filing Type: DEF 14A
Importance Score:
7
ARWR
Jan 12, 2026, 5:00 PM EST
Filing Type: 8-K
Importance Score:
8
ARWR
Jan 08, 2026, 7:15 PM EST
Filing Type: 8-K
Importance Score:
9
ARWR
Jan 08, 2026, 7:11 PM EST
Filing Type: 424B5
Importance Score:
8
ARWR
Jan 08, 2026, 7:00 PM EST
Filing Type: 424B5
Importance Score:
9
ARWR
Jan 08, 2026, 6:12 AM EST
Filing Type: FWP
Importance Score:
8
ARWR
Jan 07, 2026, 9:12 PM EST
Filing Type: FWP
Importance Score:
8
ARWR
Jan 06, 2026, 8:15 PM EST
Filing Type: 424B5
Importance Score:
8
ARWR
Jan 06, 2026, 8:05 PM EST
Filing Type: 424B5
Importance Score:
8
ARWR
Jan 06, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
9